Supplemental material
Open access
1,290
Views
26
CrossRef citations to date
0
Altmetric
Original Articles
Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
Qiaoling Ruan These authors contribute equally to the article.;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Qihui Liu These authors contribute equally to the article.;Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Feng SunDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Lingyun ShaoDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Jialin JinDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Shenglei YuDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Jingwen AiDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
, Bingyan ZhangDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, China
& Wenhong ZhangDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai200040, ChinaCorrespondence[email protected]
show all
Pages 1-8
|
Received 30 Aug 2015, Accepted 16 Nov 2015, Published online: 25 Jan 2019
Related Research Data
Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations.
Source:
American Society for Microbiology
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
Source:
Frontiers Media SA
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.